Franco Recchia, MD
Retina Specialist · Nashville, TNNPI 1356438469
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.0%), consulting fees and other — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Genentech USA, Inc. at 47.7% of the total.
Across 101 payments — averaging $715.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$34K
- US Retina LLC$17K
- Alimera Sciences, Inc.$9K
- Genentech, Inc.$8K
- F. Hoffmann-la Roche AG$3K
- Alcon$507
- plus $1K from 14 others
Across 2 payments — averaging $2062.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$4K
What the payments were for
- Consulting fees$19,99528%
- Speaking & faculty fees$23,89233%
- Travel & lodging$7,45010%
- Food & beverage$4,1936%
- Ownership interest$7,26210%
- Other$9,50213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 27 | $34,493 |
| US Retina LLC | 7 | $16,764 |
| Alimera Sciences, Inc. | 18 | $9,198 |
| Genentech, Inc. | 13 | $7,509 |
| F. Hoffmann-la Roche AG | 2 | $2,552 |
| Alcon | 4 | $507 |
| Harrow Eye, LLC | 2 | $316 |
| AbbVie(2 entities) | 9 | $160 |
| Regeneron Healthcare Solutions, Inc. | 2 | $142 |
| Dutch Ophthalmic, USA | 1 | $140 |
| Bausch & Lomb Americas Inc. | 1 | $138 |
| Astellas Pharma US Inc | 4 | $98 |
| Regeneron | 1 | $75 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $49 |
| Biogen | 2 | $48 |
| Novartis | 2 | $29 |
| Carl Zeiss Meditec, Inc. | 1 | $25 |
| Eyepoint US, Inc. | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUSVIMO$17,573
- VABYSMO$17,565
- Iluvien$8,770
- Lucentis$8,370
- Non-Covered Product$1,299
- Constellation$258
- NGENUITY$148
- EVA, combined machine$140
- TISSUEBLUE$140
- STELLARIS$138
- EYLEA$122
- Unity$102
How this compares
$72,294 in reported general payments places this provider in the 85th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 160 | $8,066 |
| Brimonidine Tartrate | 27 | $2,719 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 82 | $1,302 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $1,152 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $393 |
| Latanoprost | 35 | $281 |
| Ketorolac Tromethamine | 15 | $243 |
| Ciprofloxacin Hcl | 17 | $237 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Nashville
- Carl AwhNashville$1.3M
- Peter SonkinNashville$949K
- Brandon BusbeeNashville$566K
- Eric SchneiderNashville$134K
- David ReichsteinNashville$114K
- Akshay ThomasNashville$108K
- Everton ArrindellNashville$39K
- Roy WallaceNashville$19K
- Kenneth MoffatNashville$17K
- Brigid MarshallNashville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.